NIH-funded researchers begin trial of Shigella vaccine candidates

(NIH/National Institute of Allergy and Infectious Diseases) Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children. The Phase I clinical trial, funded by NIAID, part of NIH, will evaluate the vaccines for safety and their ability to induce immune responses among 90 healthy adults ages 18 to 45 years.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news